Credit Agricole’s Vanda Pharmaceuticals VNDA Stock Holding History

Credit Agricole’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-62,784	Closed	-$703K	–	1658
2016 Q2	$703K	Sell	62,784 -38,000	-38%	-$368K	﹤0.01%	1100
2016 Q1	$843K	Hold	100,784	–	–	﹤0.01%	956
2015 Q4	$938K	Hold	100,784	–	–	﹤0.01%	1022
2015 Q3	$1.14M	Hold	100,784	–	–	0.01%	979
2015 Q2	$1.28M	Hold	100,784	–	–	0.01%	979
2015 Q1	$937K	Sell	100,784 -111,400	-53%	-$1.26M	﹤0.01%	1092
2014 Q4	$2.96M	Hold	212,184	–	–	0.01%	789
2014 Q3	$2.2M	Sell	212,184 -11,863	-5%	-$155K	0.01%	872
2014 Q2	$3.63M	Buy	224,047 +126,821	+130%	+$1.69M	0.02%	726
2014 Q1	$1.58M	Buy	+97,226	New	+$1.38M	0.01%	917

Other funds holding VNDA

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Credit Agricole's VNDA Position: Q3 2016 in Review

Credit Agricole sold out of Vanda Pharmaceuticals (VNDA) in Q3 2016, closing a stake of 62,784 shares — an estimated $703K sold.

Credit Agricole first reported a position in VNDA in Q1 2014 and held it in 10 quarters. The position peaked at $3.63M in Q2 2014. 140 funds tracked by Wall St. Rank hold VNDA as of Q3 2016.

Credit Agricole reported no remaining Vanda Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
Credit Agricole sold 62,784 Vanda Pharmaceuticals shares in Q3 2016, an estimated $703K.
Credit Agricole first reported a position in Vanda Pharmaceuticals in Q1 2014 and held it in 10 quarters.
Credit Agricole's Vanda Pharmaceuticals position peaked at $3.63M in Q2 2014.
140 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2016.

Based on Credit Agricole's 13F filing for Q3 2016, filed 10 Nov 2016.